Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis N Verma, Y Vinik, A Saroha, NU Nair, E Ruppin, G Mills, T Karn, V Dubey, ... Science advances 6 (34), eaba8968, 2020 | 96 | 2020 |
Evaluation of inhibitory activities of plant extracts on production of LPS-stimulated pro-inflammatory mediators in J774 murine macrophages N Verma, SK Tripathi, D Sahu, HR Das, RH Das Molecular and cellular biochemistry 336, 127-135, 2010 | 96 | 2010 |
PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition N Verma, O Keinan, M Selitrennik, T Karn, M Filipits, S Lev Nature communications 6 (1), 6064, 2015 | 83 | 2015 |
Effect of seeds of Achyranthes aspera on the immune responses and expression of some immune-related genes in carp Catla catla R Chakrabarti, PK Srivastava, N Verma, JG Sharma Fish & shellfish immunology 41 (1), 64-69, 2014 | 82 | 2014 |
Targeting of PYK2 synergizes with EGFR antagonists in basal-like TNBC and circumvents HER3-associated resistance via the NEDD4–NDRG1 axis N Verma, AK Müller, C Kothari, E Panayotopoulou, A Kedan, ... Cancer research 77 (1), 86-99, 2017 | 70 | 2017 |
Anti-Inflammatory effects of shea butter through inhibition of iNOS, COX-2, and cytokines via the Nf-Kb pathway in LPS-activated J774 macrophage cells N Verma, R Chakrabarti, RH Das, HK Gautam Journal of Complementary and Integrative Medicine 9 (1), 1-11, 2012 | 53 | 2012 |
Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer SY Shin, AK Müller, N Verma, S Lev, LK Nguyen PLoS computational biology 14 (6), e1006192, 2018 | 37 | 2018 |
HER family in cancer progression: From discovery to 2020 and beyond R Kumar, B George, MR Campbell, N Verma, AM Paul, C Melo-Alvim, ... Advances in cancer research 147, 109-160, 2020 | 33 | 2020 |
PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein A Kedan, N Verma, A Saroha, M Shreberk-Shaked, AK Müller, NU Nair, ... Cell death & disease 9 (10), 985, 2018 | 30 | 2018 |
Symposium report: breast cancer in India—trends, environmental exposures and clinical implications JA McDonald, R Rao, M Gibbons, R Janardhanan, S Jaswal, R Mehrotra, ... Cancer Causes & Control 32 (6), 567-575, 2021 | 23 | 2021 |
Evaluation of antiinflammatory activity of Dracaena cinnabari Balf. F. resin. HRDRKG Deepika Gupta, Nandini Verma Indian J Nat. Prod. Resour. 5, 215-222., 2014 | 15* | 2014 |
iNOS-targeted 10-23 DNAzyme reduces LPS-induced systemic inflammation and mortality in mice N Verma, SK Tripathi, I Chaudhury, HR Das, RH Das Shock 33 (5), 493-499, 2010 | 13 | 2010 |
Silencing of TNF-α receptors coordinately suppresses TNF-α expression through NF-κB activation blockade in THP-1 macrophage N Verma, I Chaudhury, D Kumar, RH Das FEBS letters 583 (17), 2968-2974, 2009 | 11 | 2009 |
9-cis-canthaxanthin exhibits higher pro-apoptotic activity than all-trans-canthaxanthin isomer in THP-1 macrophage cells V Venugopalan, N Verma, HK Gautam, PP Saradhi, RH Das Free radical research 43 (2), 100-105, 2009 | 9 | 2009 |
Fibronectin gene up-regulation by Arnica montana in human macrophages: Validation by real-time polymerase chain reaction assay M Marzotto, F Arruda-Silva, P Bellavite Homeopathy 109 (03), 140-145, 2020 | 8 | 2020 |
Screening of thermophiles from municipal solid waste and their selective antimicrobial profile V Venugopalan, B Singh, N Verma, P Nahar, TC Bora, RH Das, ... Curr. Res. Bacteriol 1 (1), 17-22, 2008 | 6 | 2008 |
Inducible nitric oxide synthase (iNOS) targeted 10-23 DNAzyme reduces lipopolysaccharide (LPS) induced systemic inflammation and mortality in mice N Verma, SK Tripathi, I Chaudhury, HR Das, RH Das Shock, 2009 | 3 | 2009 |
GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition N Chaudhary, BS Choudhary, S Patra, S Malvankar, A Shivashankar, ... bioRxiv, 2023.05. 18.541287, 2023 | 1 | 2023 |
Correction: Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4–NDRG1 Axis N Verma, AK Müller, C Kothari, E Panayotopoulou, A Kedan, ... Cancer Research 80 (2), 362-362, 2020 | 1 | 2020 |
Silencing the disease messengers: progress and prospects in developing nucleic acid based therapeutics RH Das, N Verma RNAi Technol 5, 85-96, 2016 | 1 | 2016 |